{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:48:22Z","timestamp":1775486902603,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02589","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T13:52:06Z","timestamp":1576763526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Secondary C1q Deficiency in Activated PI3K\u03b4 Syndrome Type 2"],"prefix":"10.3389","volume":"10","author":[{"given":"Ying","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sira","family":"Nanthapisal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebun","family":"Omoyinmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Neth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Speckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Genomics England Research Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0181874","DOI":"10.1371\/journal.pone.0181874","article-title":"Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis","volume":"12","author":"Omoyinmi","year":"2017","journal-title":"PLoS ONE."},{"key":"B2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/key445","article-title":"Monogenic mimics of Behcet's disease in the young","volume":"58","author":"Papadopoulou","year":"2019","journal-title":"Rheumatology (Oxf)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3389\/fimmu.2018.02524","article-title":"Cutaneous vasculitis and digital ischaemia caused by heterozygous gain-of-function mutation in C3","volume":"9","author":"Omoyinmi","year":"2018","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fimmu.2018.00735","article-title":"Cutaneous vasculitis and recurrent infection caused by deficiency in complement factor I","volume":"9","author":"Nanthapisal","year":"2018","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-019-08738-9","article-title":"Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review","author":"Jamee","year":"2019","journal-title":"Clin Rev Allergy Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/pai.12585","article-title":"Activated PI3Kdelta syndrome type 2: two patients, a novel mutation, and review of the literature","volume":"27","author":"Olbrich","year":"2016","journal-title":"Pediatr Allergy Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s10875-016-0281-6","article-title":"Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature","volume":"36","author":"Petrovski","year":"2016","journal-title":"J Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/nbt.2422","article-title":"Interpreting noncoding genetic variation in complex traits and human disease","volume":"30","author":"Ward","year":"2012","journal-title":"Nat Biotechnol."},{"key":"B12","first-page":"32","article-title":"The biosynthesis of C1q, the collagen-like and Fc-recognizing molecule of the complement system","volume":"89","author":"Loos","year":"1989","journal-title":"Behring Inst Mitt."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study","volume":"138","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","article-title":"Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two","volume":"179","author":"Bravo","year":"2017","journal-title":"Clin Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191","article-title":"Effective \u201cactivated PI3Kdelta syndrome\u201d-targeted therapy with the PI3Kdelta inhibitor leniolisib","volume":"130","author":"Rao","year":"2017","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"9682803","DOI":"10.1155\/2017\/9682803","article-title":"De Novo PTEN mutation in a young boy with cutaneous vasculitis","volume":"2017","author":"Mauro","year":"2017","journal-title":"Case Rep Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fimmu.2015.00317","article-title":"Emerging and novel functions of complement protein C1q","volume":"6","author":"Kouser","year":"2015","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4049\/jimmunol.153.4.1430","article-title":"Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation","volume":"153","author":"Chen","year":"1994","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1517\/14740338.2013.752814","article-title":"Adverse events associated with mTOR inhibitors","volume":"12","author":"Pallet","year":"2013","journal-title":"Expert Opin Drug Saf."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/bmt.2017.189","article-title":"Successful bone marrow transplantation in two sisters with activated phosphoinositide 3-kinase delta syndrome 2","volume":"52","author":"Sugiyama","year":"2017","journal-title":"Bone Marrow Transplant."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T06:52:57Z","timestamp":1695538377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2019.02589"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02589","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"article-number":"2589"}}